Review of NICE Technology Appraisal Guidance No 152; Drug-eluting stents for the treatment of coronary artery disease

Proposal to defer the review

The planned date for review of the above guidance was May 2010.

This is the date at which the Institute decides whether sufficient new evidence has emerged for the Appraisal Committee to be asked to undertake a full review appraisal.

The Institute has carried out a search for information relevant to this appraisal, and has found that to the best of its knowledge, no new evidence has been published that would have a material effect on the original guidance. 

Consequently we propose that the decision to review the original guidance be deferred until June 2012 when the evidence base will again be assessed to ascertain the need for a review of the guidance.

In order to be completely confident that this is appropriate, we are asking all relevant consultees and commentators, to inform us of any evidence which would suggest that a review would be beneficial.  Please see appendix A for a full list of the organisations we have contacted. 

August 2010

• Appendix A: Matrix of stakeholders
• Appendix B: Proposal paper presented to the Institute's Guidance Executive